Hosokawa Yoichiro, Shirato Hiroki, Nishioka Takashi, Tsuchiya Kazuhiko, Chang Ta-Chen, Kagei Kenji, Ohomori Keiichi, Obinata Ken-ichi, Kaneko Masayuki, Miyasaka Kazuo, Nakamura Motoyasu
Department of Dental Radiology, Health Sciences University of Hokkaido, Tobetsu, Japan.
Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):71-8. doi: 10.1016/s0360-3016(03)00507-8.
To investigate the importance of total treatment time on the outcome of external beam radiotherapy (EBRT) followed by internal brachytherapy for the treatment of oral tongue carcinoma.
Ninety-four patients with T1-T2N0 squamous cell carcinoma of the oral tongue were treated using 35-40 Gy EBRT followed by 35-40 Gy interstitial (137)Cs brachytherapy between 1985 and 1995. The interval between the end of EBRT and the start of interstitial treatment varied for numerous unavoidable reasons, with a mean of 25.3 days and standard deviation of 3.5 days. The median follow-up period was 59.1 months (range 6-146).
The actuarial survival rate of all cases was 78.4% at 5 years. The 5-year local control rate for those with T1 and T2 was 92.8% and 62.7%, respectively (p < 0.05). The local control rate of the primary tumor in patients with a total treatment time >43 days was statistically lower than that of patients with a total treatment time < or =43 days in all patients (p < 0.05) and in the subgroup of Stage T2 patients (p < 0.05). Multivariate analysis revealed that the local control rates in all cases were significantly related to the T stage (T2 or not), total treatment time (>43 days or not), and location of disease (posterior or not). Regression analysis for 5-year local control as a function of treatment duration showed a 2% loss of local control per day of treatment extension >30 days (r = 0.94, p < 0.01).
The total treatment time was associated with the local control rate in the RT of oral tongue carcinoma. The loss in local control was estimated to be 2.0% per additional day in our series for oral tongue carcinoma.
探讨总治疗时间对口腔舌癌外照射放疗(EBRT)联合组织间近距离放疗疗效的重要性。
1985年至1995年间,94例T1-T2N0期口腔舌鳞状细胞癌患者接受了35-40 Gy的EBRT,随后接受35-40 Gy的组织间(137)Cs近距离放疗。由于诸多不可避免的原因,EBRT结束至组织间治疗开始的间隔时间各不相同,平均为25.3天,标准差为3.5天。中位随访期为59.1个月(范围6-146个月)。
所有病例的5年精算生存率为78.4%。T1和T2患者的5年局部控制率分别为92.8%和62.7%(p<0.05)。在所有患者中(p<0.05)以及T2期亚组患者中(p<0.05),总治疗时间>43天的患者原发肿瘤局部控制率在统计学上低于总治疗时间≤43天的患者。多因素分析显示,所有病例的局部控制率与T分期(是否为T2)、总治疗时间(是否>43天)以及病变部位(是否为后部)显著相关。将5年局部控制率作为治疗持续时间的函数进行回归分析显示,治疗延长>30天,局部控制率每天损失2%(r=0.94,p<0.01)。
总治疗时间与口腔舌癌放疗的局部控制率相关。在我们的口腔舌癌系列研究中,估计每延长一天局部控制率损失2.0%。